Clinical Trial Update: Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of tirzepatide on cardiovascular and metabolic parameters in obese adults with congenital heart disease; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Obesity

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Obesity & Overweight, Adult Congenital Heart Disease | Phase 4 | Status: NOT_YET_RECRUITING